Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: Results of a prospective randomised trial

European Journal of Cancer

Volumn 37, Issue 16, 2001, Pages 1994-2002

  Hejna, M ^a   Kostler W J ^a   Raderer, M ^a   Steger, G G ^a   Brodowicz, T ^a   Scheithauer, W ^a   Wiltschke, C ^a   Zielinski, C C ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Chemotherapy; GM CSF; Oral mucositis; Topical

Indexed keywords

AMPHO MORONAL LUTSCHTABLETTEN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BETAISODONA MUND ANTISEPTIKUM; FLUOROURACIL; LIDOCAINE; POVIDONE IODINE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BREAST CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; GRANULOCYTE; HUMAN; LEUKOCYTE COUNT; MALE; MOUTH LESION; MOUTHWASH; MUCOSA INFLAMMATION; PANCREAS CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; STOMACH CARCINOMA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTHWASHES; POVIDONE-IODINE; PROSPECTIVE STUDIES; PROTECTIVE AGENTS; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STOMATITIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034774287     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00132-0     Document Type: Article

References (31)

1. Studies on the prevention of 5-fluorouracil-induced oral mucositis
2. Management of mucositis during therapy
3. Oral complications of cancer therapy
4. Oral complications in patients with advanced cancer
5. Oral complications in patients receiving treatment for malignancies other than the head and neck
6. Local use of GM-CSF for severe mucositis
7. Fungal infections complicating acute leukemia
8. Nystatin prophylaxis in leukemia and lymphoma
9. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis after haematopoetic stem-cell transplantation
10. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin
11. Effects of recombinant human granulocyte-macrophage colony stimulating factor on neutropenia in patients with congenital agranulocytosis
12. Granulocyte colony-stimulating factor and granulocyte-macrophage stimulating-factor induce human endothelial cells to migrate and proliferate
13. Granulocyte-macrophage colony stimulating factor ad of granulocyte colony stimulating factor granulocyte-macrophage colony stimulating factor: Differential action on incisional wound healing
14. Topical granulocyte-macrophage colony-stimulating factor in patients with cancer and impaired wound healing
15. Novel responses of human skin to intradermal recombinant granulocyte-macrophage colony stimulating factor: Langhans cell recruitment, keratinocyte growth, and enhanced wound healing
16. Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcoma
17. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity of chemotherapy for transitional cell carcinoma of the urothelium
18. GM-CSF mouthwashes as treatment for mucositis in BMT patients
19. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients
20. Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head ad neck radiotherapy
21. Effect of topical oral G-CSF on oral mucositis: A randomized placebo-controlled trail
22. A database for mucositis induced by cancer chemotherapy
23. Gastrointestinal toxicities
24. Oropharyngeal mucositis complicating bone marrow transplantation: Prognostic factors ad the effect of chlorhexidine mouth rinse
25. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis
26. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy
27. Risk factors for chemotherapy-induced oral mucositis: Dental appliances, oral hygiene, previous oral lesions, and history of smoking
28. Aging and cell renewal of oral epithelium
29. Role of granulocyte-macrophage colony stimulating factor in chemoradiotherapy-induced oral mucositis
30. The oral flora as a source of septicemia in patients with acute leukemia
31. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies